T790M Plasma Testing Methodology Comparison and Clinical Validation

The patient will need to have T790M+ testing

Blood count and standard chemistry testing to ensure patient meets inclusion/exclusion criteria

ECG to ensure absence of any cardiac abnormality

Slit-lamp testing performed to ensure patients do not have any eye abnormalities or symptoms

Patients to be provided with AZD9291 every 6 weeks (+/- 7 days)

The patient will need to have plasma AZD9291 testing before treatment